Novartis AG
F:NOTA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Novartis AG
F:NOTA
|
CH |
|
S
|
Service Corporation International
F:SVC
|
US |
|
E
|
Endesa SA
DUS:ENA
|
ES |
|
F
|
First Advantage Corp
F:0MS
|
US |
|
OUTFRONT Media Inc
F:76C0
|
US |
|
C
|
Canadian Imperial Bank of Commerce
F:CAI
|
CA |
|
R
|
Renault SA
F:RNL1
|
FR |
|
E
|
Exelon Corp
XMUN:PEO
|
US |
|
F
|
Flex Ltd
XMUN:FXI
|
SG |
|
P
|
Proto Labs Inc
XMUN:PRZ
|
US |
|
A
|
Avista Corp
XBER:AV6
|
US |
|
L
|
Laboratory Corporation of America Holdings
SWB:LAB
|
US |
|
A
|
AXA SA
XMUN:AXA
|
FR |
|
W
|
Whitehaven Coal Ltd
XBER:WC2
|
AU |
Wall St Price Targets
NOTA Price Targets Summary
Novartis AG
According to Wall Street analysts, the average 1-year price target for NOTA is 135.26 EUR with a low forecast of 97.94 EUR and a high forecast of 201.4 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NOTA's stock price target?
Price Target
135.26
EUR
According to Wall Street analysts, the average 1-year price target for NOTA is 135.26 EUR with a low forecast of 97.94 EUR and a high forecast of 201.4 EUR.
What is the Revenue forecast for Novartis AG?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Revenue has been 0%. The projected CAGR for the next 8 years is 2%.
What is the Operating Income forecast for Novartis AG?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Operating Income has been 4%. The projected CAGR for the next 8 years is 6%.
What is the Net Income forecast for Novartis AG?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Net Income has been 3%. The projected CAGR for the next 8 years is 7%.
